Global Biosimilar Monoclonal Antibodies Market (2018-2024): Rising Demand for Biosimilar Drugs Owing to their Cost Effectiveness - ResearchAndMarkets.com
The "Biosimilar Monoclonal Antibodies Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.The report predicts the global biosimilar monoclonal antibodies market to grow with a CAGR of 55.2% over the forecast period of 2018-2024.
The study on biosimilar monoclonal antibodies market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The report on biosimilar monoclonal antibodies market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global biosimilar monoclonal antibodies market over the period of 2016 to 2024.
- Rising Demand for Biosimilar Drugs Owing to their Cost Effectiveness
- Prevalence of Chronic Diseases among Geriatric Population
- Unfavorable Government Regulations in Developed Economies
- High Cost Associated With Manufacturing Process
- Growing Collaboration among the Local Players
- Pfizer Inc.
- Novartis AG
- Reliance Life Sciences
- Coherus BioSciences Inc.
- Boehringer Ingelheim GmbH
- BioXpress Therapeutics S.A.
- Intas Pharmaceuticals Limited
- Genor BioPharma Co. Ltd.
Key Topics Covered
2. Executive Summary
3. Global Biosimilar Monoclonal Antibodies Market Overview
4. Biosimilar Monoclonal Antibodies Market Macro Indicator Analysis
5. Global Biosimilar Monoclonal Antibodies Market by Application
6. Global Biosimilar Monoclonal Antibodies Market by Drug Class
7. Global Biosimilar Monoclonal Antibodies Market by Region
8. Company Profiles and Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/h6lvqt/global_biosimilar?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005341/en/